- MOQ100 Carton
- Supply TypeManufacturer, Exporter, Supplier, Retailer
- Preferred Buyer Location All over the world
Midostaurin, sold under the brand name Rydapt & Tauritmo both by Novartis, is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia, myelodysplastic syndrome and advanced systemic mastocytosis.
View More Details